158 related articles for article (PubMed ID: 37490345)
1. Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide-mediated dysregulation of claudin expression.
Kho J; Polak U; Jiang MM; Odom JD; Hunter JV; Ali SM; Burrage LC; Nagamani SC; Pautler RG; Thompson HP; Urayama A; Jin Z; Lee B
JCI Insight; 2023 Sep; 8(17):. PubMed ID: 37490345
[TBL] [Abstract][Full Text] [Related]
2. Requirement of argininosuccinate lyase for systemic nitric oxide production.
Erez A; Nagamani SC; Shchelochkov OA; Premkumar MH; Campeau PM; Chen Y; Garg HK; Li L; Mian A; Bertin TK; Black JO; Zeng H; Tang Y; Reddy AK; Summar M; O'Brien WE; Harrison DG; Mitch WE; Marini JC; Aschner JL; Bryan NS; Lee B
Nat Med; 2011 Nov; 17(12):1619-26. PubMed ID: 22081021
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation.
Jin Z; Kho J; Dawson B; Jiang MM; Chen Y; Ali S; Burrage LC; Grover M; Palmer DJ; Turner DL; Ng P; Nagamani SC; Lee B
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33373331
[TBL] [Abstract][Full Text] [Related]
4. Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension.
Kho J; Tian X; Wong WT; Bertin T; Jiang MM; Chen S; Jin Z; Shchelochkov OA; Burrage LC; Reddy AK; Jiang H; Abo-Zahrah R; Ma S; Zhang P; Bissig KD; Kim JJ; Devaraj S; Rodney GG; Erez A; Bryan NS; Nagamani SCS; Lee BH
Am J Hum Genet; 2018 Aug; 103(2):276-287. PubMed ID: 30075114
[TBL] [Abstract][Full Text] [Related]
5. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.
Erez A; Nagamani SC; Lee B
Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):45-53. PubMed ID: 21312326
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide is required for lung alveolarization revealed by deficiency of argininosuccinate lyase.
Jin Z; Jiang MM; Lee B
Hum Mol Genet; 2023 Dec; 33(1):33-37. PubMed ID: 37738569
[TBL] [Abstract][Full Text] [Related]
7. Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.
Diez-Fernandez C; Hertig D; Loup M; Diserens G; Henry H; Vermathen P; Nuoffer JM; Häberle J; Braissant O
J Inherit Metab Dis; 2019 Nov; 42(6):1077-1087. PubMed ID: 30907007
[TBL] [Abstract][Full Text] [Related]
8. Argininosuccinate lyase deficiency.
Nagamani SC; Erez A; Lee B
Genet Med; 2012 May; 14(5):501-7. PubMed ID: 22241104
[TBL] [Abstract][Full Text] [Related]
9. Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.
Nagamani SC; Campeau PM; Shchelochkov OA; Premkumar MH; Guse K; Brunetti-Pierri N; Chen Y; Sun Q; Tang Y; Palmer D; Reddy AK; Li L; Slesnick TC; Feig DI; Caudle S; Harrison D; Salviati L; Marini JC; Bryan NS; Erez A; Lee B
Am J Hum Genet; 2012 May; 90(5):836-46. PubMed ID: 22541557
[TBL] [Abstract][Full Text] [Related]
10. Mutations and polymorphisms in the human argininosuccinate lyase (ASL) gene.
Balmer C; Pandey AV; Rüfenacht V; Nuoffer JM; Fang P; Wong LJ; Häberle J
Hum Mutat; 2014 Jan; 35(1):27-35. PubMed ID: 24166829
[TBL] [Abstract][Full Text] [Related]
11. Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study.
Elkhateeb N; Olivieri G; Siri B; Boyd S; Stepien KM; Sharma R; Morris AAM; Hartley T; Crowther L; Grunewald S; Cleary M; Mundy H; Chakrapani A; Lachmann R; Murphy E; Santra S; Uudelepp ML; Yeo M; Bernhardt I; Sudakhar S; Chan A; Mills P; Ridout D; Gissen P; Dionisi-Vici C; Baruteau J
Epilepsia; 2023 Jun; 64(6):1612-1626. PubMed ID: 36994644
[TBL] [Abstract][Full Text] [Related]
12. Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer.
Baruteau J; Perocheau DP; Hanley J; Lorvellec M; Rocha-Ferreira E; Karda R; Ng J; Suff N; Diaz JA; Rahim AA; Hughes MP; Banushi B; Prunty H; Hristova M; Ridout DA; Virasami A; Heales S; Howe SJ; Buckley SMK; Mills PB; Gissen P; Waddington SN
Nat Commun; 2018 Aug; 9(1):3505. PubMed ID: 30158522
[TBL] [Abstract][Full Text] [Related]
13. Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria.
Hu L; Pandey AV; Balmer C; Eggimann S; Rüfenacht V; Nuoffer JM; Häberle J
J Inherit Metab Dis; 2015 Sep; 38(5):815-27. PubMed ID: 25778938
[TBL] [Abstract][Full Text] [Related]
14. Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors.
Jalil S; Keskinen T; Juutila J; Sartori Maldonado R; Euro L; Suomalainen A; Lapatto R; Kuuluvainen E; Hietakangas V; Otonkoski T; Hyvönen ME; Wartiovaara K
Am J Hum Genet; 2024 Apr; 111(4):714-728. PubMed ID: 38579669
[TBL] [Abstract][Full Text] [Related]
15. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.
Yang S; Chen Y; Deng X; Jiang W; Li B; Fu Z; Du M; Ding R
J Mol Neurosci; 2013 Oct; 51(2):352-63. PubMed ID: 23494638
[TBL] [Abstract][Full Text] [Related]
17. Optimizing therapy for argininosuccinic aciduria.
Nagamani SC; Lee B; Erez A
Mol Genet Metab; 2012 Sep; 107(1-2):10-4. PubMed ID: 22841516
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.
Barna L; Walter FR; Harazin A; Bocsik A; Kincses A; Tubak V; Jósvay K; Zvara Á; Campos-Bedolla P; Deli MA
Fluids Barriers CNS; 2020 Feb; 17(1):5. PubMed ID: 32036791
[TBL] [Abstract][Full Text] [Related]
19. Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects.
Baruteau J; Diez-Fernandez C; Lerner S; Ranucci G; Gissen P; Dionisi-Vici C; Nagamani S; Erez A; Häberle J
J Inherit Metab Dis; 2019 Nov; 42(6):1147-1161. PubMed ID: 30723942
[TBL] [Abstract][Full Text] [Related]
20. mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.
Gurung S; Timmermand OV; Perocheau D; Gil-Martinez AL; Minnion M; Touramanidou L; Fang S; Messina M; Khalil Y; Spiewak J; Barber AR; Edwards RS; Pinto PL; Finn PF; Cavedon A; Siddiqui S; Rice L; Martini PGV; Ridout D; Heywood W; Hargreaves I; Heales S; Mills PB; Waddington SN; Gissen P; Eaton S; Ryten M; Feelisch M; Frassetto A; Witney TH; Baruteau J
Sci Transl Med; 2024 Jan; 16(729):eadh1334. PubMed ID: 38198573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
